SURGICAL ONCOLOGY-OXFORD, cilt.27, sa.3, ss.485-489, 2018 (SCI-Expanded)
Purpose: We aimed to investigate the prognostic effect of primary tumor resection (PTR) prior to bevacizumab-based treatments in unresectable metastatic colorectal cancer (mCRC).